Metabolomic Profiling Reveals Common Metabolic Alterations in Plasma of Patients with Toxoplasma Infection and Schizophrenia

Genes (Basel). 2022 Aug 19;13(8):1482. doi: 10.3390/genes13081482.

Abstract

Toxoplasma gondii is an opportunistic protozoan parasite known to affect the human brain. The infection has been associated with an increased incidence of schizophrenia; however, the link between the two conditions remains unclear. This study aimed to compare the plasma metabolome of schizophrenia and non-schizophrenia subjects with or without Toxoplasma infection. Untargeted metabolomic profiling was carried out by liquid chromatography-mass spectrometry. Elevation of the α-hydroxyglutaric acid level and reduced adenosine monophosphate, inosine, hypoxanthine and xanthine were found in the subjects with either toxoplasmosis or schizophrenia alone. These results suggest that purine catabolism is a common metabolic alteration in Toxoplasma infection and schizophrenia. The roles of these metabolites on the pathogenesis of schizophrenia in relation to Toxoplasma infection warrant further studies.

Keywords: Toxoplasma gondii; metabolomics; purine catabolism; schizophrenia; toxoplasmosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Metabolome
  • Metabolomics
  • Schizophrenia*
  • Toxoplasma* / metabolism
  • Toxoplasmosis*

Grants and funding

This study was funded by the Research Incentive Grant (GGP-2017-033) from the Universiti Kebangsaan Malaysia.